Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
In handing down the sentence, a federal judge said that Josh Verne carried out the scheme over multiple years with “sheer persistence." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results